These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26332760)

  • 41. Bone disease in CKD: a focus on osteoporosis diagnosis and management.
    Miller PD
    Am J Kidney Dis; 2014 Aug; 64(2):290-304. PubMed ID: 24726630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
    Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):413-425. PubMed ID: 33245331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Osteoporosis in CKD.
    Khairallah P; Nickolas TL
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):962-969. PubMed ID: 29487093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation between body mass index and bone mineral density among haemodialysis patients with chronic kidney disease.
    Castillo RF; de la Rosa RJ
    J Ren Care; 2009 Mar; 35 Suppl 1():57-64. PubMed ID: 19222733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of bone turnover markers in chronic kidney disease-mineral and bone disorders.
    Chiang C
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():11-13. PubMed ID: 28429547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Renal osteodystrophy].
    Imanishi Y
    Clin Calcium; 2007 Oct; 17(10):1521-8. PubMed ID: 17906403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New bone imaging techniques in children with chronic kidney disease].
    Bacchetta J; Boutroy S; Delmas PD; Cochat P
    Arch Pediatr; 2009 Nov; 16(11):1482-90. PubMed ID: 19766468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.
    Cannata-Andía JB; Martín-Carro B; Martín-Vírgala J; Rodríguez-Carrio J; Bande-Fernández JJ; Alonso-Montes C; Carrillo-López N
    Calcif Tissue Int; 2021 Apr; 108(4):410-422. PubMed ID: 33190187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bone and Nutrition. Nutrition care of renal osteodystrophy].
    Tanaka S; Ito M
    Clin Calcium; 2015 Jul; 25(7):1057-62. PubMed ID: 26119320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone Fragility Fractures in CKD Patients.
    Pimentel A; Ureña-Torres P; Bover J; Luis Fernandez-Martín J; Cohen-Solal M
    Calcif Tissue Int; 2021 Apr; 108(4):539-550. PubMed ID: 33219822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Non-invasive Diagnosis of Bone Disorders in CKD.
    Bover J; Ureña-Torres P; Cozzolino M; Rodríguez-García M; Gómez-Alonso C
    Calcif Tissue Int; 2021 Apr; 108(4):512-527. PubMed ID: 33398414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone loss in chronic kidney disease: Quantity or quality?
    Zheng CM; Zheng JQ; Wu CC; Lu CL; Shyu JF; Yung-Ho H; Wu MY; Chiu IJ; Wang YH; Lin YF; Lu KC
    Bone; 2016 Jun; 87():57-70. PubMed ID: 27049042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.
    Evenepoel P; D'Haese P; Bacchetta J; Cannata-Andia J; Ferreira A; Haarhaus M; Mazzaferro S; Lafage Proust MH; Salam S; Spasovski G; Cozzolino M;
    Nephrol Dial Transplant; 2017 Oct; 32(10):1608-1613. PubMed ID: 28339949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
    Cejka D; Parada-Rodriguez D; Pichler S; Marculescu R; Kramer I; Kneissel M; Gross T; Reisinger A; Pahr D; Monier-Faugere MC; Haas M; Malluche HH
    Kidney Int; 2016 Oct; 90(4):828-34. PubMed ID: 27528549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K
    Clin Calcium; 2012 Jul; 22(7):979-86. PubMed ID: 22750929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone biopsy and histomorphometrical analysis].
    Tsukamoto Y
    Clin Calcium; 2012 Jul; 22(7):1019-24. PubMed ID: 22750934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic kidney disease mineral and bone disorder: A guide for general practice.
    Sridharan K
    Aust J Gen Pract; 2023; 52(1-2):52-57. PubMed ID: 36796773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Biomechanical Testing for the Assessment of Bone Quality in an Experimental Model of Chronic Kidney Disease.
    Oksztulska-Kolanek E; Znorko B; Michałowska M; Pawlak K
    Nephron; 2016; 132(1):51-8. PubMed ID: 26680019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.